期刊文献+

微量白蛋白尿在社区医院糖尿病早期肾损害诊治中的意义

The Significance of Microalbuminuria in Community Hospitals for Treatment of the Diabetes Early Kidney Damage
下载PDF
导出
摘要 目的:探讨糖尿病患者早期肾脏损害的指标。方法:采用放射免疫法,测定健康组和糖尿病患者组非应激、非剧烈运动状态下24h尿的尿微量白蛋白量。结果:糖尿病患者的尿微量白蛋白含量明显高于健康者,两组比较有统计学差异。结论:尿微量白蛋白是糖尿病病人早期肾损害一个非常敏感的指标,对早期发现、早期治疗糖尿病肾病有很重要的意义,而且检测方法简单易行,应在社区医院广泛开展。 Objective:Elplore the guide line about kidney damage at early period in diabetes patients.Method:Use radioimmunoassay to mesure 24 h microalbuminuria in healthy group and diabetes patients group in the state of none-stree and no exercises.Result:The microalbuminuria of diabetes patient group is obviously higher than the healthy group,it is a very significant difference between the two groups.Conclusion:Microalbuminuria is a sensitive guide line about kidney damage at early period in diabetes patients,which is with an important significance to inchoate discover and inchoate cure the DM,and moerover detection method is simple and easy,so microalbuminuria should be widely used in community hospitals.
出处 《实用中西医结合临床》 2011年第3期71-72,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
关键词 微量白蛋白尿 糖尿病肾病 社区医院 Microalbuminuria DM Community hospitals
  • 相关文献

参考文献6

二级参考文献20

  • 1陆菊明,潘长玉,田慧,邓心新,蒋赐恩,姚晨,陆小平,孔祥涛,王淑玉.糖耐量低减患者的尿白蛋白排出率观察[J].中国糖尿病杂志,1995,3(4):210-213. 被引量:22
  • 2[3]American Diabetes Association.Diabetic nephropathy.DiabetesCare,2003,26(Suppl 1):S94-S98.
  • 3[4]Ritz E,Orth SR.Nephropathy in patients with type 2diabetesmellitus.N Engl J Med,1999,341:1127-1133.
  • 4[5]Remuzzi G,Schieppati A,Ruggenenti P.Nephropathy in patientswith type 2diabetes.N Engl J Med,2002,346:1145-1151.
  • 5Volpini RA,Da Silva CG,Costa RS,et al.Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.Diabetes Metab Res Rev,2003,19(1):43-51.
  • 6Wolf G,N eilson EG.A ngiotensin as a renal growth factor.JAm Soc Nephrol,1993,3:1531-1540.
  • 7DEEDWANIA P C.Hypertension and diabetes: new therapeutice option[J]. Arch Inter Med,2000,160:1 585-1 594.
  • 8American Diabetes Association. Managemant of dyslipidemia in adults with diabetes[J].Diabetes Care,2001,24:S58-S61.
  • 9ODA H,KEANE W F. Recent advances in statins and the kidney[J]. Kidney Int,1999,71(suppl):S2-S5.
  • 10NAKAMARA T,USHIYAMA C,OSADA S,et al. Pioglitazons reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria[J]. Metabolism,2001,50(10):1 193.

共引文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部